BRIEF published on 05/14/2025 at 21:35, 11 months 24 days ago Integrated BioPharma, Inc. Posts Financial Results for Q1 2025 Financial Results Revenue Growth Operating Income Q1 2025 Key Customers
PRESS RELEASE published on 05/14/2025 at 21:30, 11 months 24 days ago Integrated BioPharma Reports Results for its Quarter Ended March 31, 2025 Integrated BioPharma, Inc. reports a 6.1% revenue increase for Q1 2025 compared to Q1 2024. Company had operating income and net income growth. Key focus on core business and expanding customer base Financial Results Revenue Increase Net Income Operating Income Integrated BioPharma
BRIEF published on 02/13/2025 at 22:00, 1 year 2 months ago Integrated BioPharma Reports Quarterly Results with Increased Revenue Revenue Growth Q4 Results Operating Income Customer Base Expansion Integrated BioPharma
BRIEF published on 02/13/2025 at 22:00, 1 year 2 months ago Integrated BioPharma publie ses résultats trimestriels avec un chiffre d'affaires en hausse Croissance Des Revenus Résultat D'exploitation Biopharmacie Intégrée Élargissement De La Clientèle Résultats Du 4e Trimestre
PRESS RELEASE published on 02/13/2025 at 21:55, 1 year 2 months ago Integrated BioPharma Reports Results for its Quarter Ended December 31, 2024 Integrated BioPharma, Inc. reports 9.6% increase in revenue to $12.6 million for quarter ended Dec 31, 2024. Operating income of $0.2 million. Detailed financial results provided Financial Results Revenue Increase Quarterly Report Operating Income Integrated BioPharma
BRIEF published on 11/13/2024 at 23:38, 1 year 5 months ago Integrated BioPharma, Inc. annonce ses résultats financiers du troisième trimestre 2024 Croissance Des Revenus Revenu Net Résultats Du 3ème Trimestre 2024 Biopharmacie Intégrée Diversification De La Clientèle
BRIEF published on 11/13/2024 at 23:38, 1 year 5 months ago Integrated BioPharma, Inc. Announces Q3 2024 Financial Results Revenue Growth Net Income Integrated BioPharma Customer Diversification Q3 2024 Results
PRESS RELEASE published on 11/13/2024 at 23:33, 1 year 5 months ago Integrated BioPharma Reports Results for its Quarter Ended September 30, 2024 Integrated BioPharma, Inc. reports revenue growth in Q3 2024 with net income of $0.3 million. Diversification of customer base leads to increased financial performance Revenue Growth Financial Performance Diversification Q3 2024 Integrated BioPharma
BRIEF published on 09/20/2024 at 23:45, 1 year 7 months ago Integrated BioPharma annonce ses résultats financiers pour le trimestre et l'exercice clos le 30 juin 2024 Résultats Financiers Résultat D'exploitation Revenu Net Revenu Biopharmacie Intégrée
BRIEF published on 09/20/2024 at 23:45, 1 year 7 months ago Integrated BioPharma Announces Financial Results for Quarter and Fiscal Year Ended June 30, 2024 Financial Results Revenue Net Income Operating Income Integrated BioPharma
Published on 05/08/2026 at 21:00, 22 minutes ago NOA Lithium Receives Biannual Renewal to Rio Grande's Exploration Permits and Provides Corporate Updates
Published on 05/08/2026 at 15:55, 5 hours 27 minutes ago Class 1 Nickel and Technologies Ltd. Announces Private Placement and Share for Debt Offering
Published on 05/08/2026 at 15:00, 6 hours 22 minutes ago Jaguar Health Regains Compliance with Nasdaq's Publicly Held Shares Requirement and Receives Additional Extension, Until May 18, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule
Published on 05/08/2026 at 14:55, 6 hours 27 minutes ago Nepra Foods Inc. to Present at the 16th Annual LD Micro Invitational
Published on 05/08/2026 at 14:30, 6 hours 52 minutes ago Unusual Machines Hosts Live Drone Ecosystem Demonstrations at XPONENTIAL 2026
Published on 05/08/2026 at 20:38, 44 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 2 hours 9 minutes ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 2 hours 20 minutes ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 1 day 2 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 1 day 2 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 1 day 2 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 1 day 2 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 1 day 2 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
